Skip to content
Search

Latest Stories

‘UK South Asians five times more prone to diabetes’

Type 2 diabetes is up to five times more predominant in South Asian populations living in the UK as compared with their white European counterparts, health experts have said.

Managing diabetes is now a global issue mainly because those seen at higher risk of the disease are people of South Asian origin who comprise nearly a quarter of the world's population, said Dr Andrew Willis from the Centre for Ethnic Health Research during a webinar organised by the Danish pharmaceutical company Novo Nordisk on Tuesday (October 26).


Approximately 388,000 people of South Asian origin who live in the UK have diagnosed or undiagnosed type 2 diabetes. Therefore, keeping the South Asian population groups in consideration while making effective strategies for diabetes is really important, he added.

Dr Willis explained that obesity, genetics, sedentary lifestyle and unhealthy diet were the main factors that put people at the risk of developing type 2 diabetes.

Diabetes is a chronic condition occurring when the body cannot produce enough insulin or is unable to effectively use it to manage the blood sugar level.

Obesity, accounting for 80-85 per cent, is the leading risk factor for diabetes, experts said.

People of South Asian ethnicity are predisposed to higher body fat and lower muscle mass at lower Body Mass Index, thereby increasing the risk of becoming diabetic, they added.

Moreover, research has suggested that South Asian ethnicity carry genes that put them at a higher risk of type 2 diabetes than the general population.

Higher exposure of this population group to diabetes became more evident during the Covid-19 pandemic, as the chronic condition increases comorbidity, said Dr Amir Khan, TV medic and GP.

Khan said: “The risk of dying in hospital from Covid is much higher in people of South Asian ethnicity than the people of white ethnicity in the UK.”

Besides, diabetes increases the risk of cardiovascular diseases, peripheral artery disease, nerve damage, kidney failure and vision problems.

Research has shown that every year, diabetes causes more than 27,000 heart attacks and 100,000 cases of heart failure in the UK.

People of South Asian ethnicity are at a higher risk of major cardiovascular events linked to type 2 diabetes than people of white European ethnicity, experts said.

Highlighting an initiative taken up by University of Leicester on risk screening for South Asian population, Dr Avideh Nazeri, vice-president clinical development, medical, and regulatory affairs, Novo Nordisk UK, said: “This is one of the greatest initiatives... because even the risk screening that we do typically had been really of predominantly Caucasian focus.”

Barriers to manage diabetes in South Asian communities

Researchers and health experts have identified common barriers to effective management of type 2 diabetes among people of South Asian ethnicity:

  • Traditional diet: South Asian cuisine typically includes high carbohydrate foods like rice and wheat based breads -- rotis and chapattis.
  • Language barriers: More than 50 per cent of people of South Asian ethnicity in the UK are estimated not to be proficient in English
  • Access to healthcare services: Some people from minority ethnic backgrounds find it more difficult to access primary care health services
  • Stigma and social support: Some people may feel embarrassed about telling their family or community about their condition
  • Health beliefs: Health beliefs can impact diabetes management, including a preference for traditional remedies and the view that excess weight indicates good health

Community pharmacy and culturally tailored solutions

To counter these barriers and ensure better management of diabetes amongst the people of South Asian ethnicity, Dr Khan suggested that “culturally tailored” steps should be initiated.

He said a healthcare professional should try to include family members while advising patients from the South Asian background, and added that regular physical exercise and diabetic-friendly cooking should be initiated in their daily routine.

Advice that is culturally tailored to account for diverse health beliefs, cultural and linguistic needs have been shown to have positive health outcomes for this population group.

Recent research has highlighted a role for community pharmacy in diabetes prevention due to ease of accessibility and familiarity with patients and their families.

New service models should seek to integrate community pharmacy services in primary care so as to facilitate patient engagement and better communication with general practices.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less